IMPACT-CABG Trial: Implantation of CD133 + Stem Cells in Patients Undergoing Coronary Bypass Surgery—Presentation of the First Treated Patient
Case Reports in Transplantation · 2011
DOI: 10.1155/2011/685394 ↗Kurz gefasst
Fallbericht in der Zeitschrift Case Reports in Transplantation, 2011. Verfasst von Jessica Forcillo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, CHUM, 3840 Rue Saint-Urbain, Montréal, QC, Canada H2W 1T7 ; Surgery Department, Université de Montréal, Montréal, QC, …. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
The IMPACT-CABG study is the first Canadian randomized-controlled phase II clinical trial aiming to assess the effect of intramyocardial (IM) injections of CD133 + -selected stem cells in patients referred for coronary artery bypass graft (CABG) with a “chronic” myocardial infarction and persistent left ventricular dysfunction. Patients are followed for 2 years with different imaging techniques including the stress magnetic resonance to evaluate the global and regional myocardial viability. Before the beginning of the randomization, the 5 first patients are treated in an open-label fashion to assess safety and feasibility of the IM CD133 + injections. Herein, we report the first Canadian patient treated with IM injection of CD133 + cells during CABG surgery as part of the IMPACT-CABG trial.
Autor:innen und Institutionen
- Department of Cardiac Surgery, CHUM, 3840 Rue Saint-Urbain, Montréal, QC, Canada H2W 1T7 ; Surgery Department, Université de Montréal, Montréal, QC, Canada H3C 3J7.
Zitieren
APA
Forcillo, J., Stevens, L. M., Mansour, S., Prieto, I., Roy, D. C., & Noiseux, N. (2011). IMPACT-CABG Trial: Implantation of CD133 + Stem Cells in Patients Undergoing Coronary Bypass Surgery—Presentation of the First Treated Patient. Case Reports in Transplantation. https://doi.org/10.1155/2011/685394
Vancouver
Forcillo J, Stevens LM, Mansour S, Prieto I, Roy DC, Noiseux N. IMPACT-CABG Trial: Implantation of CD133 + Stem Cells in Patients Undergoing Coronary Bypass Surgery—Presentation of the First Treated Patient. Case Reports in Transplantation. 2011. doi:10.1155/2011/685394
BibTeX
@article{Forcillo2011,
author = {Forcillo, Jessica and Stevens, Louis-Mathieu and Mansour, Samer and Prieto, Ignacio and Roy, Denis-Claude and Noiseux, Nicolas},
title = {IMPACT-CABG Trial: Implantation of CD133 + Stem Cells in Patients Undergoing Coronary Bypass Surgery—Presentation of the First Treated Patient},
journal = {Case Reports in Transplantation},
year = {2011},
doi = {10.1155/2011/685394}
}
EUVIMED